Oxidative stress and inflammation program (Global Blood Therapeutics/Sanofi SA)

N/A

Report date: 2025/01/26 16:32:52
NME

Base Information

Drug NameOxidative stress and inflammation program (Global Blood Therapeutics/Sanofi SA)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesSanofiGlobal Blood Therapeutics Inc
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A